Belize vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Belize
100.0%
in 2024
Europe (WHO region)
90.0%
in 2024
Belize rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Belize
- Europe (WHO region)
How they compare
Belize currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Belize's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 4 times across 15 shared years of data; in 2005 it was Belize ahead.
Belize ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 25.1% | 15.1% | Europe (WHO region) |
| 2010s | 35.6% | 62.6% | 27.0% | Europe (WHO region) |
| 2020s | 91.6% | 93.8% | 2.2% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belize or Europe (WHO region)?
- Belize, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belize and Europe (WHO region)?
- 10.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Europe (WHO region)?
- 15 years are reported by both, from 2005 to 2024.
- How do Belize and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Belize ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.